Advanced search
Publication Cover
Cancer Management and Research Volume 13, 2021 - Issue
Submit an article Journal homepage
94
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Prognostic Analysis of Patients with Primary Extranodal Lymphoma: A Retrospective Study

Hanying Shen1 Blood Disease Institute, Xuzhou Medical University, Xuzhou, Jiangsu, 221000, People’s Republic of China
,
Lingling Jiang1 Blood Disease Institute, Xuzhou Medical University, Xuzhou, Jiangsu, 221000, People’s Republic of China
,
Linlin Nie1 Blood Disease Institute, Xuzhou Medical University, Xuzhou, Jiangsu, 221000, People’s Republic of China
,
Xiaohui Fan1 Blood Disease Institute, Xuzhou Medical University, Xuzhou, Jiangsu, 221000, People’s Republic of China
,
Yanqiu Xu1 Blood Disease Institute, Xuzhou Medical University, Xuzhou, Jiangsu, 221000, People’s Republic of China
,
Lingling Yin2 Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, 221002, People’s Republic of China
,
Linyan Xu1 Blood Disease Institute, Xuzhou Medical University, Xuzhou, Jiangsu, 221000, People’s Republic of China;3 Key Laboratory of Bone Marrow Stem Cell, Xuzhou, Jiangsu, 221000, People’s Republic of China
,
Jieyun Xia2 Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, 221002, People’s Republic of China
,
Zhenyu Li1 Blood Disease Institute, Xuzhou Medical University, Xuzhou, Jiangsu, 221000, People’s Republic of China;2 Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, 221002, People’s Republic of China;3 Key Laboratory of Bone Marrow Stem Cell, Xuzhou, Jiangsu, 221000, People’s Republic of China
,
Feng Zhu1 Blood Disease Institute, Xuzhou Medical University, Xuzhou, Jiangsu, 221000, People’s Republic of China;2 Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, 221002, People’s Republic of China;3 Key Laboratory of Bone Marrow Stem Cell, Xuzhou, Jiangsu, 221000, People’s Republic of ChinaCorrespondence[email protected] [email protected]
ORCID Iconhttps://orcid.org/0000-0002-9356-2154
ORCID Icon &
Kailin Xu1 Blood Disease Institute, Xuzhou Medical University, Xuzhou, Jiangsu, 221000, People’s Republic of China;2 Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, 221002, People’s Republic of China;3 Key Laboratory of Bone Marrow Stem Cell, Xuzhou, Jiangsu, 221000, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0003-1375-1084
ORCID Icon show all
Pages 2171-2180 | Published online: 02 Mar 2021

References

  • Krol AD, le Cessie S, Snijder S, et al. Primary extranodal non-Hodgkin’s lymphoma (NHL): the impact of alternative definitions tested in the Comprehensive Cancer Centre West population-based NHL registry. Ann Oncol. 2003;14:131–139. doi:10.1093/annonc/mdg00412488305
  • Padhi S, Paul TR, Challa S, et al. Primary extra nodal non Hodgkin lymphoma: a 5 year retrospective analysis. Asian Pac J Cancer Prev. 2012;13:4889–4895. doi:10.7314/APJCP.2012.13.10.488923244076
  • Zelenetz AD, Gordon LI, Abramson JS, et al. NCCN guidelines insights: b-cell lymphomas, version 3.2019. J Natl Compr Canc Netw. 2019;17:650–661. doi:10.6004/jnccn.2019.002931200358
  • Horwitz SM, Ansell SM, Ai WZ, et al. NCCN guidelines insights: t-cell lymphomas, version 2.2018. J Natl Compr Canc Netw. 2018;16:123–135. doi:10.6004/jnccn.2018.000729439173
  • Cheson BD, Fisher RI, Barrington SF, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32:3059–3068. doi:10.1200/JCO.2013.54.880025113753
  • Lister TA, Crowther D, Sutcliffe SB, et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin’s disease: cotswolds meeting. J Clin Oncol. 1989;7:1630–1636. doi:10.1200/JCO.1989.7.11.16302809679
  • Zucca E, Copie-Bergman C, Ricardi U, et al. Gastric marginal zone lymphoma of MALT type: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24:vi144–vi148. doi:10.1093/annonc/mdt34324078657
  • Burg G, Drummer R, Dommann S, et al. Pathology of cutaneous T-cell lymphoma. Hematol Oncol Clin North Am. 1995;9:961–995. doi:10.1016/S0889-8588(18)30053-48522491
  • Cairo MS, Sposto R, Gerrard M, et al. Advanced stage, increased lactate dehydrogenase, and primary site, but not adolescent age (≥ 15 years), are associated with an increased risk of treatment failure in children and adolescents with mature B-cell non-Hodgkin’s lymphoma: results of the FAB LMB 96 study. J Clin Oncol. 2012;30:387–393. doi:10.1200/JCO.2010.33.336922215753
  • Tomita N, Taguri M, Hashimoto C, et al. Evaluation of soluble interleukin-2 receptor and serum lactate dehydrogenase in malignant lymphoma. Ann Hematol. 2015;94:1935–1937. doi:10.1007/s00277-015-2448-226208667
  • Bento L, Díaz-López A, Barranco G, et al. New prognosis score including absolute lymphocyte/monocyte ratio, red blood cell distribution width and beta-2 microglobulin in patients with diffuse large B-cell lymphoma treated with R-CHOP: spanish Lymphoma Group Experience (GELTAMO). Br J Haematol. 2020;188:888–897. doi:10.1111/bjh.1626331782146
  • Seo S, Hong JY, Yoon S, et al. Prognostic significance of serum beta-2 microglobulin in patients with diffuse large B-cell lymphoma in the rituximab era. Oncotarget. 2016;7:76934–76943. doi:10.18632/oncotarget.1273427764777
  • Al Diab AR, Aleem A, Qayum A, et al. Clinico-pathological pattern of extranodal non-Hodgkin’s lymphoma in Saudi Arabia. Asian Pac J Cancer Prev. 2011;12:3277–3282.22471466
  • Batchelor TT, Grossman SA, Mikkelsen T, et al. Rituximab monotherapy for patients with recurrent primary CNS lymphoma. Neurology. 2011;76:929–930. doi:10.1212/WNL.0b013e31820f2d9421383331
  • Intragumtornchai T, Rotnakkarin P, Sutcharitchan P, et al. Prognostic significance of the immunophenotype versus the International Prognostic Index in aggressive non-Hodgkin’s lymphoma. Clin Lymphoma. 2003;4:52–55. doi:10.3816/CLM.2003.n.01412837156
  • Shannon EM, MacQueen IT, Miller JM, et al. Management of primary gastrointestinal non-hodgkin lymphomas: a population-based survival analysis. J Gastrointest Surg. 2016;20:1141–1149. doi:10.1007/s11605-016-3129-826992397
  • Lou LL, Cen XN, Ou JP, et al. [Clinical and pathological analysis of 236 patients with primary extranodal lymphoma]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014;22:85–92. doi:10.7534/j.issn.1009-2137.2014.01.01824598657
  • Hartmann K, Illing A, Leithäuser F, Baisantry A, Quintanilla-Martinez L, Rudolph KL. Gene dosage reductions of Trf1 and/or Tin2 induce telomere DNA damage and lymphoma formation in aging mice. Leukemia. 2017;31:2853. doi:10.1038/leu.2017.224
  • Sarkozy C, Salles G, Falandry C. The biology of aging and lymphoma: a complex interplay. Curr Oncol Rep. 2015;17:32. doi:10.1007/s11912-015-0457-x26003736
  • Roth P, Martus P, Kiewe P, et al. Outcome of elderly patients with primary CNS lymphoma in the G-PCNSL-SG-1 trial. Neurology. 2012;79:890–896. doi:10.1212/WNL.0b013e318266fcb222895585

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.